Applied Therapeutics, Inc.
DelistedCIK 1697532fmd_0PS8F3BNRSGPWGFBQDYNE71RSZManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2025, 31 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | 10 | 0 |
| Research and development | 11 | 32 | 62 | 63 | 56 | 54 | 49 |
| Total operating expenses | 14 | 46 | 94 | 106 | 83 | 75 | 105 |
| Operating income | (14) | (46) | (94) | (106) | (83) | (65) | (104) |
| Other non-operating income (expense) | (3) | 0 | 1 | 0 | 0 | (55) | (1) |
| Net income | (17) | (46) | (94) | (106) | (83) | (120) | (106) |
| Net income to common shareholders | (17) | (46) | (94) | (106) | (83) | (120) | – |